AIM ImmunoTech, Inc. (AIM)
1.25
+0.46
(+58.23%)
USD |
NYAM |
Feb 13, 16:00
1.10
-0.15
(-12.00%)
After-Hours: 20:00
AIM ImmunoTech Free Cash Flow : -13.33M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Halozyme Therapeutics, Inc. | 602.40M |
| Agenus, Inc. | -89.31M |
| Curis, Inc. | -30.09M |
| LadRx Corp. | -- |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.079M |
| Cash from Investing (Quarterly) | 0.296M |
| Cash from Financing (Quarterly) | 6.654M |
| Free Cash Flow Per Share (Quarterly) | -2.424 |
| Free Cash Flow to Equity (Quarterly) | -4.612M |
| Free Cash Flow to Firm (Quarterly) | -4.931M |
| Free Cash Flow Yield | -57.79% |